// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Late Breaking Abstract - Increased type 2 inflammation in patients with asthma post rhinovirus infection

Thomas Southworth - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

Step-Down of ICS in stable asthmatics in primary care: An observational study

Kevin Gruffydd-Jones - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

beclometasone

Pilot project to provide spirometry inreach sessions to hostels/homeless shelters in Tower Hamlets, London

Claire Davey - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incremental Shuttle Walk Test predicts survival in non-Group 1 Pulmonary Hypertension without a ceiling effect

Catherine Billings - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

N/A

A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey

Michael Kreuter - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

COPD Management needs Hospital and Community multi-disciplinary teams to work together to optimise patient care.

Michael Apps - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Safety profile of a novel peptide, PIN201104, with potential to act as a disease modifying, broad spectrum treatment for asthma

Jeannette Watson - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Cardiorenal syndrome

N/A

Motile cilia structure and function in patients with mutations in the outer dynein arm heavy chain DNAH9

Amelia Shoemark - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

Nitric oxide

What is the best technique to extract bacterial DNA from sputum?

Martina Oriano - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

lysostaphin

Changing causes of mortality for people with chronic respiratory diseases

Alicia Gayle - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The role of innate lymphoid cells in early life lung infection

Dawid Swieboda - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Do the 2012 GLI multi-ethnic reference equations show a good fit for healthy black South Africans?

Sara-Jane Smith - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What’s in a postcode? Socioeconomic deprivation in the primary care 2015-17 COPD audit

Philip Stone - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Oral corticosteroid (OCS)-sparing effect of tralokinumab in severe, uncontrolled asthma: the TROPOS study

William Busse - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

CAT-354

Tapioca starch powder as a new cause of occupational asthma in bakers

Ruth Wiggans - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Nitric oxide

Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?

Rodric V Francis - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Late Breaking Abstract - Psychometric validation of QOL-PCD, Adolescent, Child and Parent Proxy questionnaires assessed their reliability and validity

Laura Behan - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Application of a predictive formula for hypoxic challenge testing in patients with interstitial lung disease

Sunil Patel - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Measuring lung inhomogeneity in asthma using a novel non-invasive technique

Nicholas Smith - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Salbutamol

Potential causes of variability in latent phenotypes of childhood wheeze

Ceyda Oksel - European Respiratory Society (ERS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved